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Background: Fairly recent data highlight the role of programmed cell death and autoimmunity, as potentially
important factors in the pathogenesis of chronic obstructive airway diseases. The purpose of our research was to
determine the influence of apoptotic factors on the immunity of patients with atopic bronchial asthma according
to the degree of severity.
Method: The study was performed on the peripheral blood of patients with atopic bronchial asthma with different
severity. The Immunological aspects were determined with ELISA, the fluorimetric method and the method of
precipitation with polyethylene glycol. And the quantification of the parameters of the programmed cell death was
performed by the method of flow cytometry and electron microscopy method.
Results: The data obtained from morphological and biochemical parameters show the deregulation of
Programmed Death of lymphocytes of patients with atopic bronchial asthma but individual for each group of
patients. This dysfunction might induce the secretion of autoantibodies against DNA. This could explain the
accumulation of circulating immune complex with average size considered as the most pathogenic in patients with
bronchial asthma especially in the patients of serious severity. It should be noted that Patients with bronchial
asthma of mild and severe severity had different way and did not have the same degree of deficiency of the
immune system.
Conclusion: These data suggested that apoptotic factor of lymphocytes may play an important role in controlling
immunity of patients with atopic bronchial asthma.
Keywords: Programmed cell death, Immunity, Atopic Bronchial AsthmaIntroduction
Each pathological process resembles a stereotypical reac-
tion of the organism due to the action of various patho-
gens. Although there is a genetic and immunological
specificity, all species highly organized (including
humans) show practically the same stereotyped re-
sponses. Programmed cell death (PCD), which is similar* Correspondence: sweetiebj@yahoo.fr
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article, unless otherwise stated.to a natural physiological process [1-3] is a very illustra-
tive example of the stereotypical reactions. An important
progress in the study of the PCD concern the morpho-
biochemical changes observed during apoptosis [4-6]. In
this respect, with the current classification of programmed
cell death we can note: PCD of type I- apoptosis, PCD of
type II - autophagy and necrosis as PCD of type III [7]. If be-
fore, the decisive role of PCD was attributed to induce this
process (physiological: during apoptosis, supra-physiological
during necrosis), now the differences from apoptosis and ne-
crosis of the surrounding cells and the organism are in the
foreground. On the other hand, the process of autophagy in
normal cells is a possibility of renewal of organelles [8-10]. It
was established that autophagy plays a vital role duringentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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[11]. The deregulation of this process plays an important
role in many diseases such as: neurodegenerative diseases
(Alzheimer’s and Parkinson’s) [7,10,12], myodystrophy and
cardiomyopathy diseases [13,14], the aging and infections
[12] and malignant tumors [7]. The intensification of the
study on the process of cell death is due to the fact that
there are several methods existing nowadays available to rec-
ord the various manifestations of PCD and to analyze mo-
lecular mechanisms [15] which are tightly related to
mechanisms of other important events (eg cell activation
and associated biological signaling). The study of PCD
proved to be productive and fruitful for the understanding
of a certain number of important processes, including im-
mune homeostasis and oncogenesis. In connection with the
phenomenon of PCD, it was necessary to review a certain
number of conceptual data of pathophysiology. In eukary-
otes, PCD was previously considered as a negative process
in view of the importance of identifying the phenomenon of
necrosis. Nowadays, we have a better understanding of
PCD: on the one hand, the death of cells in the body is seen
as a natural process, and the existence of a multicellular or-
ganism requires a balanced relationship between life and
death. Nevertheless, the role of apoptosis in the develop-
ment of the pathological process is less obvious. It seems
that this form of cell death (as opposed to necrosis) is not
an indispensable component of the typical pathological
process, but rather the malfunction of apoptosis is the cause
of a certain number of diseases [6,16,17]. Thus, the rele-
vance of this problem is defined by a correlation of the mal-
function of PCD process with most diseases, including
autoimmune diseases. The identification of the mechanisms
of deregulation of the PCD associated with some specific
diseases allows understanding the etiopathology of these dis-
eases. The goal of our research was to determine the im-
munological characteristics and the biochemical and
morphological parameters of PCD of lymphocytes of pa-
tients with atopic bronchial asthma (ABA) according to
their degree of severity.
Materials and methods
Patients and blood sampling
The study was carried on the peripheral blood from rela-
tively healthy individuals (n = 21) and asthmatic patients (n
= 92). The group of patients was composed of individuals
with different severity of asthma: 38 patients of mild severity
with an average of 39 +/- 5 years, 20 patients of moderate
severity (42+/- 5) and 34 patients of severe severity (42 +/-
5). At the time of blood collection, patients were hospital-
ized in the detachment of Pneumology and were not treated
with glucocorticoid. All the donors were non smokers and
were selected after consent. The collection of venous blood
from donors was done in the morning before taking break-
fast. The diagnosis of atopic bronchial asthma wasestablished by medical doctors on the basis of data from the
allergic anamnesis, the results of allegen skin prick test, epi-
demiology, and the experiments of nasal provokers and in-
halers. The work was conducted under the rules of the
Committee of Ethics in the Laboratory of Clinical Immun-
ology and Allergy of RKB.
Detection of antibody - antiDNA by enzyme
immunoassay
The determination of the rate of antibody anti-double
stranded DNA was performed by enzyme-linked im-
munosorbent assay (ELISA) [18], previously optimized
in the laboratory of the State University of Kazan. The
lyophilized DNA of erythrocyte of chicken was used as
antigen. The blood serum samples were incubated for
40 minutes at 56 degrees of Celsius to inactivate the pro-
teins of the complement system and to dissociate the
immune complex. For the detection of the antibodies as-
sociated with DNA in the wells of the ELISA plate,
peroxidase-conjugated to antibody against human anti-
IgG was used. The response of the coloring of ELISA re-
action was detected by spectrophotometer “Multiskan”
in units of optical density at a wavelength of 492 nm.
Determination of extracellular DNA concentration
The determination of the concentration of extracellular
DNA was performed by the fluorimetric method with
the aid of the colouring Hoechst 33342 (bisbenzimide)
as fluorochrome. The level of fluorescence in solutions
was measured in quartz cuvettes with 0.6 ml of volume
using a fluorescence spectrophotometer “Hitachi MPF-
4” (Japan) at an excitation wavelength of 358 nm and an
emission wavelength of 458 nm. To determine the rate
of fluorescence of DNA in solution, we took into ac-
count the fluorescence of Hoechst solution (0.24 μg)
contained in a TNE buffer.
Determination of circulating immune complexes (CIC) by the
method of precipitation with polyethylene glycol (PEG)
The rate of CIC in the serum was determined by the
method based on the selective precipitation of antigen-
antibody complexes in 4.17% PEG having a molecular
weight of 6000, followed by a photometric determination
of the density of the precipitate.
Separation of CIC by the precipitation method with PEG
to obtain CIC from the blood serum of patients with
atopic bronchial asthma, 0.5 ml of serum was incubated
with 0.5 ml of 7.5% PEG in 0.1 M borate buffer for
1 hour at 4°C. The precipitate was washed twice with
3.5% PEG in 0.1 M buffer, and centrifuged at 2500 rpm/
min for 20 min at 4°C. And then the sediment sus-
pended in 0.5 ml of phosphate buffered saline (PBS) was
added.
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Lymphocytes were isolated by the standard method of
zonal centrifugation proposed by Patel et al. [19] with a
mixture of Ficoll-verograffin (ρ = 1077 g cm-1) [20,21].
This method consists of isolating 95% of T- lymphocytes
and their viability was determined by the trypan blue ex-
clusion method [22].
Culture of lymphocytes
The cells obtained (2 × 106) were diluted in 1 ml of the
RPMI-1640 medium in plank made of plastic with flat
bottom (Nung), then supplemented with 10% serum of
foetal calf and 10 μl of L-glutamine (200 μg/ml) (Flow)
[23]. The cells were cultured with or without dexa-
methasone (final concentration of 10-4М) and then sam-
ples were incubated in СО2-incubator (5% СО2) for 1 -
6 days [24,25].
Ultrastructural study
To study the morphology of the cells, cells obtained
after zonal centrifugation were precipitated successively
in 2.5% glutaraldehyde and 1% OsO4 for 1 hour [26].
The sample was then immersed in Epon 810 after being
dehydrated with ethanol (30-96 degrees of Celsius), in
acetone and propylene oxide. Then the cutting was real-
ized with the aid of ultra-microtome LKB-3 followed by
the observation with an electronic microscope (Hitachi
125, Japan) [27] after placing the material in the uranyl
acetate and lead citrate for the contraction.
Determination of apoptosis
the quantification of apoptosis of lymphocytes was per-
formed by the method of flow cytometry on FACSCali-
bur device (“Весton Dickinson”) with the use of some
parameters, such as the determination of the fragmenta-
tion of DNA by the iodide propidium (IP) (“Sigma”)
[28], the translocation of membrane phosphatidylserines
to the surface of lymphocytes using merocyanine
(МС540), the measuring of the variation in mitochon-
drial membrane potential of lymphocytes according to
the fluorescence intensity CMX-Ros (“Molecular
Probes”) [29]. More than 10, 000 cells were counted on
each variant of the experiment.
Statistical analysis
the analysis was performed using Excel program and
Statistics 5.0. Comparison of ranges of variation was
done with non-parametric criteria of Kryckaya Yollica
and T- criteria of Manna Yitni. The authenticity of the
frequency difference of the indices encountered was de-
termined using the method of Fischer and t-test and
partly with correction of Bonfferoni. The correctional
analysis was performed by the method of Rank and
Cpirmena-rs.Results
Immunological aspects
The content of antibodies against double-stranded DNA
and the content of CIC in the blood of patients with ABA
The rate of antibodies against double-stranded DNA in
the serum of patients with ABA and relatively healthy
donors was examined using enzyme immunoassay
(Figure 1). A minimum level of antibodies in all patient
groups was observed (Figure 1b). With the method of
correlational analysis we established a direct relationship
of dependence between the high level of IgG antibodies
– anti DNA and the severity of asthma (p = 0.0005).
A significant and direct relationship of dependence
between the level of extracellular DNA levels and that
of antibodies (IgG аnti-nDNA) was also established
(Figure 2). The attention was on the value of p
(0.00006), reflecting the strong correlation between its
significant data. The results of Figure 3 show a signifi-
cant increase (p < 0.05) of the concentration of circulat-
ing immune complexes (CIC) in the blood of asthmatic
patients compared with controls. And the concentration
was significant in asthmatic patients with serious sever-
ity. In determining the size of the CIC, we observed that
85.6% of patients with bronchial asthma had CIC of
small and medium size in the blood. On the other hand,
in relatively healthy individuals, CIC of large size were
recorded in 86% of donors and while 14% had CIC of
medium size. Thus, the results of this study showed an
increase in the concentration of CIC in asthmatic pa-
tients with a change in the size of the CIC towards the
dominant formation of CIC of small and medium size
and this rate of distribution was related to the severity of
asthma. Using the method of correlational analysis, we
have established with certainty a direct dependency rela-
tionship between the formation of CIC and antibodies to
native DNA (Figure 4a) and on the other hand, the
concentration of CIC was inversely proportional to the
concentration extracellular DNA.
Programmed cell death of lymphocytes of patients with ABA
Given that changes were observed rapidly at cellular
level, we found interesting the study of biochemical and
morphological parameters of lymphocytes of patients
with asthma in vitro after reviewing the immunological
aspects. Therefore, we conducted a comparative analysis
of morphological characteristics of lymphocytes of rela-
tively healthy donors and patients with asthma of mild
and serious severity. Thus, with the aid of transmission
electron microscopy morphological differences were
identified between the lymphocytes of control group and
the lymphocytes of patients with asthma. The electron
microscope revealed morphological and structural
changes in lymphocytes especially in the nucleus, the
chromatin and plasma membrane of patients with
Figure 1 The distribution of antibodies – anti DNA complex in relatively healthy donors and asthmatic patients: - (a) the distribution
of the level of antibody - anti DNA in the serum of donors, (b) - Distribution of the rate of antibody according to the degree of severity
of asthma (mild, moderate and severe) in percentage.
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disease. Cells with a modified structure were observed:
on the cell surface outgrowths appeared on the cell
membrane, deep invaginations and chromatin condensa-
tion and orientation of the nucleus towards the periph-
ery with intussusceptions. The structure of the
lymphocytes of the peripheral blood from asthmatic pa-
tients with serious severity differs from the structure of
the cells of clinically healthy donors and that of asth-
matics with mild severity (Figure 5). The buddings
known as the blebbing were observed on the cell mem-
brane [30]. Besides, some cells contain phagosomes with
cellular debris inside which are generally characteristics
of autophagic cells (Figure 5a,b). The study of apoptosis
in vitro now provides a better understanding of malfunc-
tion of the molecular processes during asthma. In the
culture media most of the cells die by apoptosis. But our
present study showed that this statement is not alwaysFigure 2 Relationship of dependence between the
concentration of extracellular DNA and auto-antibodies
anti DNA.true in asthmatics. To study the biochemical parameters
in vitro, we compared the level of lymphocytes for 3 and
6 days of growth in the presence or in the absence of
dexamethasone which is an inductor of apoptosis. As
shown in Figure 6, the rate of lymphocytes increased
after 3 days of growth at all the groups studied, particu-
larly in clinically healthy donors and asthmatic patients
with mild severity. On the other hand, after 6 days of
growth there was a decrease in the rate of lymphocytes
at all groups studied compared to those observed after
3 days of culture (Figure 6). The use of dexamethasone
as inductor of apoptosis resulted in an increase of 5%
(Figure 7) of the level of lymphocytes in clinically
healthy donors after 3 days of culture and a decrease of
70% (compared to 3rd day) after 6 days of culture
(Figure 8). The structure of these lymphocytes underwent
significant changes, which may indicate an inhibition of
mitotic activity of the cells of clinically healthy donors in
the presence of dexamethasone. The lymphocytes of
asthmatic patients with mild severity in the presence of
dexamethasone continue to proliferate with a slightFigure 3 Concentration of the circulating immune complex in
the serum of healthy relatively donors and asthmatic patients
according to the degree of severity (mild, moderate, and
severe). Median (Me) 0.03 for relatively healthy donors and 0.06 for
asthmatic patients.
Figure 4 Determination of dependency relationships between immunological markers of patients with asthma: a- The dependency
relationship between the concentration of CIC and the rate of antibodies anti-DNA, b- Dependency relationship between the
concentration of CIC and the concentration of extracellular DNA in the blood serum of patients with atopic bronchial asthma.
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which could explain the death of its cells following apop-
totic induction. After 6 days of culture, there was a de-
crease in lymphocytes of patients with mild severity
(Figure 8). More attention should be paid to the lympho-
cytes of asthmatic patients with serious severity: if in the
absence of dexamethasone, the level of lymphocytes in-
creased by 15% while in the presence of the apoptotic in-
ductor this level declining by 10% after 3 days of culture
as compared to the level before the cell culture. With cy-
tometry method the quantification of apoptosis of lym-
phocytes with the use of some biochemical parameters
was performed. During the study of the mechanism of
PCD, great importance was given to mitochondria as it
releases a large amount of biologically active substance
necessary for the transition from apoptosis to the final
and irreversible phase [30]. From the analysis of Figure 9,
a correlation between the number of cells with a decrease
of mitochondrial membrane potential and the expression
of phosphatidilserine on the membrane wall of lympho-
cyte of clinically healthy donors and asthmatic wasa b
Figure 5 Comparative study of Ultrastructure of lymphocytes of clinic
the degree of severity: (b)-mild severity (c) severe severity in vivo.observed. After 3 days of culture, no significant differ-
ence was found between the numbers of lymphocytes
with a decrease in membrane potential which under-
went a translocation of phosphatidylcholine on the cell
membrane (Figure 9). The level of lymphocytes with a
decrease in membrane potential in clinically healthy do-
nors has increased by 70% and 110% in asthmatics with
mild severity. On the other hand, this level is not as ex-
pressive in asthmatic of serious severity after 6 days of
culture. The incubation of lymphocytes in the presence
of dexamethasone leads to a decrease in the size of
mitochondrial membrane potential in some lymphocytes
but the dynamics vary considerably from one group to
another. In the presence of dexamethasone, a slight re-
sistance of lymphocytes of clinically healthy donors
compared to a spontaneous apoptosis was observed
(Figure 10). After 3 days of incubation with dexametha-
sone, that the number of lymphocytes with decreased
mitochondrial membrane potential was higher in asth-
matics compared to clinically healthy donors was re-
corded. The lymphocytes of patients with ABA showedc
ally healthy donors (a) and of patients with asthma according to
Figure 6 Evolution of the concentration of lymphocytes of clinically healthy donors and asthmatics with mild and severe severity after
0, 3 and 6 days cultures in vitro.
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ally healthy donor lymphocytes were characterized by a
progressive increase in PCD after 6 days of culture. A
small demonstration of early signs of spontaneous apop-
tosis and induced lymphocytes of patients with asthma
of mild and serious severity after 6 days of culture in vi-
tro might lead us to think of a disruption of this
process of PCD of type 1. The use of iodide propidium
revealed cells with fragmented DNA (Figure 11). Accord-
ing to some authors, the morphological characteristics of
DNA fragmentation were characterized by an invagination
of the nuclear membrane and condensation of chromatin
at the nuclear periphery level. In vitro studies showed no
significant difference in DNA fragmentation of lympho-
cytes (Figure 12). Even after 6 days of incubation, theFigure 7 Variation of the number of lymphocytes (mln/ml) of clinicall
severe severity) during 3 and 6 days of culture with or without dexamDNA fragmentation of lymphocytes of asthmatics was less
pronounced compared to controls. The results showed
that there were cells with fragmented DNA both in asth-
matics and in clinically healthy donors. Culture of cells
without dexamethasone (spontaneous apoptosis) for 3-
6 days resulted in a fragmentation of the DNA of lympho-
cytes (Figure 12). The number of cells with fragmented
DNA almost doubled in the culture medium of relatively
healthy donors (9% -18%) and in asthmatics with mild
severity this variation was 8% to 15% while it was 14% to
21% in asthmatics patients with serious severity. When
comparing among themselves, the development of the
process in some cultures (for 3 and 6 days) in the
presence of dexamethasone, there was a 3-fold increase
in the number of cells with characteristic traits of they healthy donors (control) and of patients with asthma (mild and
ethasone in vitro.
Figure 8 Comparative study of evolution of lymphocytes of clinically healthy donors and patients with asthma of mild and severe
severity after 3 and 6 days of culture in the presence of dexamethasone.
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donors (Figure 12) and 25% (from 8% to 10%) in asth-
matics with mild severity and 14% (ie from 14 to 16%)
in asthmatics with serious severity. We followed the dy-
namics of the induction of spontaneous apoptosis and
apoptosis induced by dexamethasone of lymphocytes
in vitro in different groups studied and it was found
that the lymphocytes of relatively normal donors
responded to the induction of spontaneous apoptosis
and induced by dexamethasone with a significant in-
crease in the number of apoptotic cells in the finalDonors
















Figure 9 Cytofluorogramme showing the quantification of the apopto
with mild and severe severity by using some parameters such as the trans
MC540 and the variation of mitochondrial membrane potential according
with dexamethasone.phase of 67% after 3 days of culture and 190% after
6 days of culture (Figure 12). As the results show, the
asthmatic cells demonstrate a resistance to apoptosis in-
duced by dexamethasone.
Discussion
In a physiopathological context, asthma is a chronic in-
flammatory disease of the respiratory airways [31] and
the choice of the study of programmed cell death is par-
ticularly due to the fact that these lymphocytes play an
irrecusable role in the pathogenesis of asthma [17,32,33].Translocation of phosphatidylserine
Without 
dexametasone With dexametasone
sis of lymphocytes of relatively healthy donors and of asthmatic
location of phosphatidylserine at the surface of lymphocytes with
to the fluorescence intensity of CMX -Ros during 3 days of culture
Figure 10 Variation of mitochondrial membrane potential of lymphocytes of relatively healthy donors and patients with atopic
bronchial asthma (mild and severe severity) after 3 and 6 days of culture with or without dexamethasone in vitro.
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the pathogenesis of asthma is and remains misunderstood
and controversial [34,35]. Increasing interest in this process
of PCD [36] in recent years was fundamental to conduct this
present study. During the development of asthma a multi-
tude of Immunogenetic mechanism and cells of immune
systems might be involved [37]. The results of immuno-
logical studies suggest a number of changes in the functional
state of lymphocytes in patients with asthma. In 1995
Szczeklik et al. [38] while studying the autoimmune status
of patients suffering from Bronchial asthma, found in the
blood some antinuclear antibodies, in any case, none of the
patients got some antibodies with NDNA, however, the
quantity of autoimmunity of the patients suffering from
bronchial pulmonary system reveal the advantage of the syn-
thesis of specific organ antibody, for example NDNA and/orFigure 11 Cytofluorogramme showing the quantification of the apop
asthmatic with mild and severe forms by using some parameter such
iodide after 3 days and 6 days of culture without or with dexametasoDNDNA autoantibodies [39]. Therefore, the level of IgG anti
-NDNA increased significantly according to the degree of se-
verity of asthma (Figure 2) and given that IgG have the abil-
ity to be locked up in the tissues, one could think of a lesion
of target tissues in progressive course with the severity de-
gree of the disease. It was revealed in patients with asthma
the significant presence of CIC of average size and consid-
ered as the most pathogenic of CIC which was formed dur-
ing a slight plethora of antigens. In relatively healthy donors,
a process of enlargement of chronic CIC was observed and
this in accordance with a proportional relationship of the
level of antigen and antibody corresponding to their elimin-
ation. It should be noted that we recorded a direct relation-
ship of dependence between the concentration of CIC and
the level of antibodies against DNA and inverse dependence
between the concentration of CIC and the concentration oftosis of lymphocytes of relatively healthy donors and of
as the determination of DNA fragmentation with propidium
ne.
Figure 12 Variation of the concentration of lymphocytes during the advance phase of apoptosis in clinically healthy donors and
asthmatics with mild and severe severity after 3 and 6 days of culture with or without dexamethasone.
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suggest the absence of a relation of equivalence between the
antibody and the antigen during the progression of the se-
verity degree of asthma. The existence of CIC in the blood
is a normal and natural phenomenon of immune reactions.
But their high level constitutes a means of diagnosing the
pathology. Circulating immune complexes of large size are
less soluble and can be easily removed by macrophages un-
like CIC of medium and small size. They dissolve easily,
making their removal difficult, which explains the CIC con-
centrations of medium and small size in asthmatics with ser-
ious severity. Therefore, the conception of the role played by
the immune process in the pathogenesis of asthma is widely
acknowledged, however, the importance of indicators of
diagnosis and individual prognosis of the immune system
remains poorly studied and in particular the accumulation
in biological fluids IG antibodies - anti DNA, abzymes with
DNAse activities, extracellular DNA, and CIC according to
the degree of severity of the disease. The results obtained in
this study allow us to suggest that these markers play a vital
role in the pathogenesis of autoimmune process during
asthma. And it is not excluded that these immunological
characteristics stemmed from other natural physiological
process. Thus, the observed difference underlined in the mi-
totic activity and the variation of the level of lymphocytes in
culture of clinically healthy donors and asthmatic shows
varying degrees of cell survival according to the severity of
the disease. From the results of our work we could note
that, based on a slowing of cell growth of lymphocytes from
asthmatics with severe severity, the lymphocytes of asth-
matics with mild severity are characteristic of lymphoproli-
ferous activity in vitro. For the researches on asthma we do
not often take into account the severity of asthma. Patients
with asthma of mild and severe severity have different back-
grounds and do not have the same degree of deficiency ofthe immune system. Failure to take into account the degree
of severity could lead to false reasoning of statistical analysis.
We found after our study that PCD of lymphocytes of pa-
tients manifested differently based on their degree of sever-
ity. Further to the adoption of the concept of PCD of type 1,
the death of lymphocytes under the influence of certain
doses of glucocorticoids was considered a classic model of
apoptosis [40,41]. Recently data were published on the sensi-
tivity of subpopulations of lymphocytes of peripheral blood
particularly cytotoxic and NK lymphocytes at a high dose of
dexamethasone [42,43]. The use of systemic glucocorticoids
increases systematically the number of lymphocytes in the
dipodiploide area. This confirms the hypothesis that the use
of corticosteroids inhibit cytokine production (Ile 3, 4, 5)
which keeps the high level of Bcl-2 anti apoptotic protein)
and consequently leads to an acceleration of apoptosis lym-
phocytes [24,44]. On the other hand, studies showed that
the use of dexamethasone leads to a decrease in the number
of migrating cells in the lungs after inhalation of specific al-
lergens [45]. The dexamethasone as inductor of apoptosis is
expected to influence the number of proliferating cells espe-
cially their reduction [46,47]. But according to our data, the
lymphocytes of asthmatic patients with mild severity showed
resistance to glucocorticoids followed by active proliferation
of its cells. There was also a decrease in the number of cells
in the late phase of apoptosis. This may be due to a mal-
function of the expression of DNase responsible for DNA
degradation. It is conceivable in view of these results that
there are indeed particularities in the course of apoptosis, in
asthmatics and this according to the degree of severity of
the disease. However, even if the conditions of the body
seem to be met to artificially induce apoptosis, the results
obtained could not totally be those of internal conditions.
Several parameters can influence the results. Researches on
apoptosis still continue nowadays, it may be other unknown
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process, of which the absence would influence the results.
Asthma can also be linked to a genetic predisposition, and
even from a race to another, differences can be observed.
Thus, results on the morphology of lymphocytes of asth-
matics were obtained. And most of lymphocytes had specific
morphological characteristics. Sometimes, cells with charac-
teristics of autophagosomes autophagy were found [29,48].
The presence of autophagy could explain the decrease of
apoptotic cells in asthmatics with mild severity. And the
PCD is universally prevalent in the world of multicellular or-
ganisms, and affects all types of tissues. It operates according
to the biochemical and morphological parameters strictly
defined and do not depend on the causes leading to the ini-
tiation of this process. In addition, the study of PCD is very
productive to understand a certain number of important
processes including immune homeostasis. Finally, according
to new data, it has become essential and indispensable to re-
view a certain number of conceptual bases of physiopathol-
ogy and immunopathology.
Conclusion
Autoimmunity and Programmed Cell Death are a highly
conserved and integrated response in normal physiological
processes playing a vital role in the pathogenesis of various
diseases, especially in the development of asthma.
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